| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/06/2005 | CN1195545C Vaginal suppository vaccine for urogenital infections |
| 04/05/2005 | US6875856 Recombinant infectious laryngotracheitis virus and uses thereof |
| 04/05/2005 | US6875853 Immunization of dairy cattle with chimeric GapC protein against streptococcus infection |
| 04/05/2005 | US6875851 Prolyl tripeptidyl peptidases nucleic acid of Porphyromonas gingivalis |
| 04/05/2005 | US6875849 Methods of recovering chaperone proteins and complexes thereof |
| 04/05/2005 | US6875848 Process for the production of virus-inactivated human gammaglobulin G |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |
| 04/05/2005 | US6875844 Recombinant or chemically synthesized intestinal carboxyesterase (ICE)amino acid sequences for treating solid tumors |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875749 Methods of facilitating vascular growth |
| 04/05/2005 | US6875748 Sodium and potassium phosphate salts, in aqueous solution, and detergents and surfactants for direct polypeptide delivery into vertebrate cells |
| 04/05/2005 | US6875737 Multivalent compounds for crosslinking receptors and uses thereof |
| 04/05/2005 | US6875612 Expression vector coding proteins for use in the treatment of tumors |
| 04/05/2005 | US6875609 Methods for the early diagnosis of ovarian cancer |
| 04/05/2005 | US6875584 Developing genetic vaccines to prevent trypanosoma infections; antiprotozoa agents; parasiticides |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/05/2005 | US6875435 In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 04/05/2005 | US6875434 Methods of treatment of Alzheimer's disease |
| 04/05/2005 | US6875432 Reduced-viscosity concentrated protein formulations |
| 04/05/2005 | US6875430 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 04/05/2005 | CA2232344C Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/05/2005 | CA2203540C Major outer membrane protein cd of moraxella |
| 04/05/2005 | CA2161798C Animal model for hepatitis virus infection |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 04/03/2005 | CA2480616A1 Specific markers for diabetes |
| 04/01/2005 | CA2444161A1 A screening method of drug for treatment of neuropathic pain |
| 03/31/2005 | WO2005028673A1 A method for detecting nipah virus and method for providing immunoprotection against henipaviruses |
| 03/31/2005 | WO2005028665A2 Campylobacter polypeptides and methods of use |
| 03/31/2005 | WO2005028634A2 Improved mva vaccines |
| 03/31/2005 | WO2005028625A2 Consensus/ancestral immunogens |
| 03/31/2005 | WO2005028618A2 Immunogenic compositions for streptococcus agalactiae |
| 03/31/2005 | WO2005028510A2 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 03/31/2005 | WO2005028505A2 Multiepitope polypeptides for cancer immunotherapy |
| 03/31/2005 | WO2005028503A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | WO2005028499A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 03/31/2005 | WO2005028498A2 Kid3 and kid3 antibodies that bind thereto |
| 03/31/2005 | WO2005028496A2 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/31/2005 | WO2005028433A2 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-β SIGNALING |
| 03/31/2005 | WO2005027964A1 Measles subunit vaccine |
| 03/31/2005 | WO2005027963A2 METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV |
| 03/31/2005 | WO2005027961A2 Chlamydia pmpd autotransporter and its role as adhesin |
| 03/31/2005 | WO2005027959A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization. |
| 03/31/2005 | WO2005027871A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 03/31/2005 | WO2005027846A2 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 03/31/2005 | WO2005027844A2 Dna vaccine compositions and methods of use |
| 03/31/2005 | WO2005027841A2 Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease |
| 03/31/2005 | WO2005027840A2 Combination approaches for generating immune responses |
| 03/31/2005 | WO2005027836A2 Immunogen |
| 03/31/2005 | WO2005027831A2 Modulators of p-selectin glycoprotein ligand 1 |
| 03/31/2005 | WO2005027829A2 Method for vaccination of poultry by bacteriophage lysate |
| 03/31/2005 | WO2005027825A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 03/31/2005 | WO2005027807A1 Pharmaceutical delivery system |
| 03/31/2005 | WO2005027774A2 Method and apparatus for preventing allergies |
| 03/31/2005 | WO2005027715A2 CRYSTALS AND STRUCTURES OF SARS-CoV MAIN PROTEASE |
| 03/31/2005 | WO2004112829A3 Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| 03/31/2005 | WO2004101780A3 Heparanase-derived peptides for vaccination of tumor patients |
| 03/31/2005 | WO2004100870A3 Compositions and methods for wt1 specific immunotherapy |
| 03/31/2005 | WO2004094466A3 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 03/31/2005 | WO2004089978A3 Use of hcv proteins |
| 03/31/2005 | WO2004087876A3 Use of red blood cells to facilitate cell activation |
| 03/31/2005 | WO2004087062A3 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 03/31/2005 | WO2004084939A3 Hiv-peptide-carrier-conjugates |
| 03/31/2005 | WO2004076677A3 Monoclonal antibody production by ebv transformation of b cells |
| 03/31/2005 | WO2004075838A3 Method and compositions for the treatment of meconium aspiration syndrome |
| 03/31/2005 | WO2004073499A3 Diagnosis of primary open angle glaucoma |
| 03/31/2005 | WO2004060320A3 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus |
| 03/31/2005 | WO2004043287A3 Novel compositions that enhance production performance in avians |
| 03/31/2005 | WO2004043233A3 Assay for autoantibodies to folate receptors |
| 03/31/2005 | WO2004039234A3 Humanized antibodies against the venezuelan equine encephalitis virus |
| 03/31/2005 | WO2004036221A3 Compositions and methods for diagnosing and treating autoimmune disease |
| 03/31/2005 | WO2004031345A3 Cytotoxic t-cell epitopes of hiv-1 virus |
| 03/31/2005 | WO2003103605A3 Flexible vaccine assembly and vaccine delivery platform |
| 03/31/2005 | WO2003070909A3 Microparticles with adsorbed polypeptide-containing molecules |
| 03/31/2005 | WO2003063897A8 Method of providing prophylaxis for tuberculosis in hiv positive individuals |
| 03/31/2005 | WO2002099054A3 Hccss as modifiers of the p53 pathway and methods of use |
| 03/31/2005 | WO2002099039A3 Peptides for chlamydophila pneumoniae vaccine and diagnosis |
| 03/31/2005 | US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening |
| 03/31/2005 | US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders |
| 03/31/2005 | US20050070694 Antagonistic anti-htnfsf13b human antibodies |
| 03/31/2005 | US20050070693 Chimeric monoclonal antibody specific to leukocyte receptor for use as tool in treatment and prevention of cell proliferative, autoimmune, prion, liver and inflammatory disorders; immunotherapy |
| 03/31/2005 | US20050070691 Polypeptides of moraxella (branhamella) catarrhalis |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070670 Novel adjuvants and copolymer compositions |
| 03/31/2005 | US20050070492 Use of a ribozyme for inhibiting gene expression; screening for oligonucleotide antisense agents |
| 03/31/2005 | US20050070491 Immunostimulatory nucleic acid molecules |
| 03/31/2005 | US20050070463 membrane proteins associated with LPSs (lipopolysaccharides), for inducing maturation of dendritic cells; membrane fraction has a proteoglycan titer, represented by the sum of the contents of galactose and of proteins, between 1.2 g/l - 3.4 g/l for galactose and between 7.5 g/l - 14.9 g/l for proteins |
| 03/31/2005 | US20050070462 Contacting with cationic polymer |
| 03/31/2005 | US20050070461 Means and methods for altering the motility of the gastrointestinal tract |
| 03/31/2005 | US20050069984 Identification of sortase gene |
| 03/31/2005 | US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders |
| 03/31/2005 | US20050069982 Using major histocompatibility complex class I receptor peptide binding cleft as tool in identifying cleavage recognition site of polypetide; tissue targeted therapy; immunotherapy |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069919 Novel human secreted proteins and polynucleotides encoding the same |
| 03/31/2005 | US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/31/2005 | US20050069878 Proteins associated with cell growth, differentiation, and death |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069869 Nucleotide sequences coding severe acute respiratory syndrome (SARS) spike glycoprotein for use as tool in development of immunoglobulins for prevention and treatment of respiratory system disorders; immunotherapy; imunodiagnostics |